Inventor · disambiguated record
David Favor
Also filed as: FAVOR DAVID · FAVOR DAVID ALAN
5 granted patents·7 pending applications·10 citations·filing 2006–2024
70Inventor score
Top patents by PatentIndex Score
12 records- 0195US11566003B2Isoquinolines as inhibitors of HPK1GENENTECH INC·Filed 2020·Granted Jan 31, 2023·4 cites·31 claims
- 0290US10407424B2Naphthyridines as inhibitors of HPK1GENENTECH INC·Filed 2018·Granted Sep 10, 2019·5 cites·72 claims
- 0381US11034692B1Naphthyridines as inhibitors of HPK1GENENTECH INC·Filed 2019·Granted Jun 15, 2021·1 cites·20 claims
- 0475US2024368170A1Cinnoline compounds and uses thereofGENENTECH INC·Filed 2024·Application pending·0 cites
- 0562US2022073520A1Cinnoline compounds and uses thereofGENENTECH INC·Filed 2021·Application pending·0 cites
- 0654US2018282282A1Isoquinolines as inhibitors of hpk1GENENTECH INC·Filed 2018·Application pending·0 cites
- 0753US12378249B2Isoquinoline compounds and uses thereofGENENTECH INC·Filed 2021·Granted Aug 5, 2025·0 cites·25 claims
- 0853US12297210B2Naphthyridine compounds and uses thereofGENENTECH INC·Filed 2021·Granted May 13, 2025·0 cites·15 claims
- 0953US2006287309A1[1,8]naphthyridin-2-ones and related compounds for the treatment of schizophreniaWARNER LAMBERT CO·Filed 2006·Application pending·0 cites
- 1053US2006287310A1[1,8]naphthyridin-2-ones and related compounds for the treatment of schizophreniaWARNER LAMBERT CO·Filed 2006·Application pending·0 cites
- 1146US2008167319A17-(4-(4-[3-chloro-2-(trifluoromethyl)phenyl]piperazin-1-yl)butoxy)-[1,8]-naphthyridin-2(1h)-onePFIZER·Filed 2008·Application pending·0 cites
- 1242US2006234997A1Tetrahydro-pyridoazepin-8-ones and related compounds for the treatment of schizophreniaWARNER LAMBERT CO·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Favor files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →